CEF11, Epstein-Barr Virus BMLF1 (280-288)

CEF11 is a synthetic HLA-A2.1-restricted CD8⁺ T-cell epitope derived from Epstein-Barr virus lytic protein BMLF1, spanning amino acids 280–288. This well-characterized viral peptide is commonly used in immunology research to study EBV-specific cytotoxic T lymphocyte responses, antigen presentation, and immune monitoring. CEF11 is valuable for epitope mapping, T-cell activation assays, vaccine-related studies, and investigations of immune control during EBV infection. It supports research into herpesvirus persistence, adaptive immune recognition, antiviral immunity, and HLA-restricted cellular responses in compatible experimental systems.

Product Name: CEF11, Epstein-Barr Virus BMLF1 (280-288)

Sequence One Letter Code: GLCTLVAML

Sequence Three Letter Code: H-Gly-Leu-Cys-Thr-Leu-Val-Ala-Met-Leu-OH

Chemical Formula:C40H73N9O11S2

Molecular Weight: 920.3

Purity: ≥ 95%

Form: Lyophilized

Storage Conditions: - 20 °C

Source / Species: EBV

Conjugation: Unconjugated

Code Nacres: NA.26